Collegium Pharmaceutical Investor Relations Material
Latest events
Q1 2025
Collegium Pharmaceutical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Collegium Pharmaceutical Inc
Access all reports
Collegium Pharmaceutical Inc. is a specialty pharmaceutical company that focuses on developing and commercializing medications for the treatment of pain and related conditions. The company emphasizes the use of innovative drug delivery technologies to create products designed to address medical needs while minimizing potential risks associated with treatment. The company is headquartered in Stoughton, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Collegium Pharmaceutical Inc
Q2 2024
Collegium Pharmaceutical Inc
Q1 2025
Collegium Pharmaceutical Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
COLL
Country
🇺🇸 United States